Sign inJoin waitlistJoin the waitlist

Dustin Deming

Professor · University of Wisconsin Hospitals and Clinics

Credentials: · · ·

History

Fellowship in Medical Oncology
2010–2012
Internal Medicine
University of Wisconsin Hospitals and Clinics
2007–2010
University of Wisconsin School of Medicine and Public Health
University of Wisconsin School of Medicine and Public Health
2003–2007

Research

Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 1,286 citations
NCCN Guidelines Insights: Colon Cancer, Version 2.2018
Journal of the National Comprehensive Cancer Network · 2018 · 777 citations
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2018 · 748 citations

Kristina Matkowskyj
25 papers
Sam Lubner
19 papers · 6 as a resident
Jeremy Kratz
18 papers · 9 as a resident
Noelle LoConte
16 papers · 6 as a resident
Al Benson
15 papers
Nataliya Uboha
14 papers · 7 as a resident
Mary Mulcahy
13 papers
Alan Venook
12 papers
Kristen Ciombor
12 papers
Smitha Krishnamurthi
12 papers
Wells Messersmith
12 papers
Christopher Willett
11 papers

Grants

Functional Optical Imaging for Rapid, Label-Free Predictions of Treatment Response and Clonal Evolution in Patient-Derived Cancer Organoids
National Cancer Institute · R01
PI · $3.1M · Morgridge Institute for Research, Inc.
2023–2028
UW Comprehensive Cancer Center Support
National Cancer Institute · P30
Project lead · $565.7K · University of Wisconsin-Madison
1997–2028
Optical Imaging to Predict Cell-Level Genetic Heterogeneity and Treatment Sensitivity in Colorectal Cancer
National Cancer Institute · R37
Contact PI · $4.2M · University of Wisconsin-Madison
2018–2025

Clinical trials

Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
Principal investigator · Recruiting · Phase 2
Dustin Deming
2024–2029
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
Principal investigator · Recruiting · Phase 2
University of Wisconsin, Madison
2023–2028
Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
Principal investigator · Active not recruiting · Phase 2
University of Wisconsin, Madison
2020–2029
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2020–2026